![Dayao Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dayao Zhao is currently the Chief Executive Officer & Director at Affamed Therapeutics (Us), Inc. He was previously the Chief Executive Officer & Director at AffaMed Therapeutics Co., Ltd. Dr. Zhao holds a doctorate degree from Harvard Medical School and Peking University Health Science Center.
| Companies | Position | Start |
|---|---|---|
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University Health Science Center
 Peking University Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
